NCT06560307 - Study of Enhanced Programming Stimulation with the Enterra® Therapy System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 25, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

GastroparesisGastroparesis NondiabeticGastroparesis Due to Diabetes Mellitus

Interventions

DEVICE

Enterra Therapy System

The Enterra® Therapy System for gastric electrical stimulation (GES) is indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years.

Trial Locations (6)

33620

RECRUITING

University of South Florida, Tampa

40202

RECRUITING

University of Louisville, Louisville

48202

RECRUITING

Henry Ford Health System, Detroit

63110

RECRUITING

Washington University, St Louis

97213

RECRUITING

Foundation for Surgical Innovation, Portland

98101

RECRUITING

Benaroya Research Institute at Virginia Mason, Seattle